LMAT LeMaitre Vascular Inc revenue, earnings and financials

For the quarter ended June 30, 2026, LeMaitre Vascular Inc reported revenue of $70.4M (up 9.6% from a year earlier), net income of $17.1M and diluted EPS of $0.74; over the last four quarters revenue was $262M and net income $65.6M; for the fiscal year ended December 2025 revenue was $250M, up 13.5% on the year before.

LMAT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $250M, gross profit $179M, operating income $67.9M, net income $57.7M (margin 23.1%), EPS $2.52
• Fiscal year ended Dec 2024: revenue $220M, gross profit $151M, operating income $52.3M, net income $44.0M (margin 20.0%), EPS $1.93
• Fiscal year ended Dec 2023: revenue $193M, gross profit $127M, operating income $36.7M, net income $30.1M (margin 15.6%), EPS $1.34
• Fiscal year ended Dec 2022: revenue $162M, gross profit $105M, operating income $26.8M, net income $20.6M (margin 12.7%), EPS $0.93
• Fiscal year ended Dec 2021: revenue $154M, gross profit $101M, operating income $36.4M, net income $26.9M (margin 17.4%), EPS $1.25

LMAT quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $70.4M (up 9.6% year over year), net income $17.1M, EPS $0.74
• Quarter ended Mar 31, 2026: revenue $66.6M (up 11.2% year over year), net income $15.7M, EPS $0.68
• Quarter ended Dec 31, 2025 (from the annual report): revenue $64.5M (up 15.7% year over year), net income $15.5M, EPS $0.69
• Quarter ended Sep 30, 2025: revenue $61.0M (up 11.4% year over year), net income $17.4M, EPS $0.75
• Quarter ended Jun 30, 2025: revenue $64.2M (up 15.0% year over year), net income $13.8M, EPS $0.60
• Quarter ended Mar 31, 2025: revenue $59.9M (up 12.0% year over year), net income $11.0M, EPS $0.48
• Quarter ended Dec 31, 2024 (from the annual report): revenue $55.7M (up 14.0% year over year), net income $11.1M, EPS $0.48
• Quarter ended Sep 30, 2024: revenue $54.8M (up 15.6% year over year), net income $11.1M, EPS $0.49
• Quarter ended Jun 30, 2024: revenue $55.8M (up 11.4% year over year), net income $11.8M, EPS $0.52
• Quarter ended Mar 31, 2024: revenue $53.5M (up 13.6% year over year), net income $9.89M, EPS $0.44
• Quarter ended Dec 31, 2023: revenue $48.9M (up 19.4% year over year), net income $8.47M, EPS $0.38
• Quarter ended Sep 30, 2023: revenue $47.4M (up 21.5% year over year), net income $7.50M, EPS $0.33
• Quarter ended Jun 30, 2023: revenue $50.1M (up 28.4% year over year), net income $8.10M, EPS $0.36
• Quarter ended Mar 31, 2023: revenue $47.1M (up 19.0% year over year), net income $6.04M, EPS $0.27
• Quarter ended Dec 31, 2022: revenue $41.0M (up 3.7% year over year), net income $5.63M, EPS $0.25
• Quarter ended Sep 30, 2022: revenue $39.0M (up 1.7% year over year), net income $5.46M, EPS $0.25
• Quarter ended Jun 30, 2022: revenue $39.0M (down 4.0% year over year), net income $3.52M, EPS $0.16
• Quarter ended Mar 31, 2022: revenue $39.6M (up 10.2% year over year), net income $6.04M, EPS $0.27
• Quarter ended Dec 31, 2021: revenue $39.5M, net income $6.18M, EPS $0.28
• Quarter ended Sep 30, 2021: revenue $38.4M, net income $6.50M, EPS $0.30

LMAT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $81.3M, share buybacks $1.82M, dividends $0.80 per share
• Fiscal year ended Dec 2024: operating cash flow $44.1M, share buybacks $1.72M, dividends $0.64 per share
• Fiscal year ended Dec 2023: operating cash flow $36.8M, share buybacks $853K, dividends $0.56 per share
• Fiscal year ended Dec 2022: operating cash flow $25.4M, share buybacks $642K, dividends $0.50 per share
• Fiscal year ended Dec 2021: operating cash flow $35.1M, share buybacks $802K, dividends $0.44 per share

LMAT balance sheet

• Jun 30, 2026: cash $26.6M, total assets $641M, total liabilities $220M, shareholders' equity $420M
• Mar 31, 2026: cash $26.9M, total assets $630M, total liabilities $223M, shareholders' equity $407M
• Dec 31, 2025: cash $28.2M, total assets $616M, total liabilities $222M, shareholders' equity $394M
• Sep 30, 2025: cash $25.5M, total assets $598M, total liabilities $219M, shareholders' equity $379M
• Jun 30, 2025: cash $27.2M, total assets $578M, total liabilities $215M, shareholders' equity $363M
• Mar 31, 2025: cash $25.3M, total assets $556M, total liabilities $208M, shareholders' equity $348M
• Dec 31, 2024: cash $25.6M, total assets $552M, total liabilities $215M, shareholders' equity $337M
• Sep 30, 2024: cash $21.0M, total assets $377M, total liabilities $46.0M, shareholders' equity $331M

What is LMAT's revenue?

LeMaitre Vascular Inc reported $262M of revenue over its last four quarters, through June 30, 2026.

Is LMAT profitable?

Yes. LeMaitre Vascular Inc earned $65.6M over the last four quarters.

What is LMAT's EPS?

Diluted earnings per share over the last four quarters were $2.86; $0.74 in the latest quarter.

Does LMAT pay a dividend?

LeMaitre Vascular Inc paid $0.80 per share in dividends in the fiscal year ended December 2025.

LMAT ownership and insider trades · All stocks